Projects per year
Safety-by-design (SbD) is paramount for risk management in synthetic biology, with genetic safeguards being a key technology for its implementation. While attractive in theory, the integration of genetic safeguards into SbD strategies is rarely exercised in practice, despite technological advances. Here we question why and what might be done about it.
|Journal||Trends in Biotechnology|
|Early online date||10 May 2020|
|Publication status||Published - Dec 2020|
- genetic safeguards
- synthetic biology
FingerprintDive into the research topics of 'Genetic Safeguards for Safety-by-design: So Close Yet So Far'. Together they form a unique fingerprint.
- 1 Finished
MycoSynVac: Engineering of Mycoplasma pneumoniae as a broad-spectrum animal vaccine
1/04/15 → 31/03/20
Project: EU research project